Broncho-munal P 3,5mg capsules 10 for kids

Country

Slovenia

Compound

1 caps.

lyophilized bacteria lysate:

Streptococcus pneumoniae,

haemophilus influenzae,

Klebsiella pneumoniae,

Klebsiella ozaenae,

Staphylococcus aureus,

Streptococcus viridans,

Streptococcus pyogenes,

Moraxella catarrhalis 3.5 mg

Excipients:

propyl gallate (anhydrous),

sodium glutamate (anhydrous),

mannitol,

magnesium stearate,

pregelatinized starch,

indigotin,

titanium dioxide,

gelatin.

pharmachologic effect

Immunomodulatory drug of bacterial origin.

Stimulates both a local cellular and humoral immune response in the mucous membrane of the respiratory tract, and a systemic immune response.

The drug stimulates the activity of alveolar macrophages, increases the number and activity of T-lymphocytes, activates peripheral monocytes, increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract, stimulates the production of protective adhesive molecules, reduces the concentration of IgE antibodies in the blood, and also increases the production of cytokines.

Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.

Indications

    infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in children aged 6 months to 12 years (for 3.5 mg capsules);    infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in adults and children over the age of 12 years (for 7 mg capsules); for the prevention of recurrent infections of the upper and lower respiratory tract (chronic bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis).

Contraindications

Increased individual sensitivity to the components of the drug.

Side effects

During the entire period of clinical use of the drug, undesirable effects were recorded extremely rarely.

In some cases: disorders of the digestive system (pain in the epigastrium, nausea, vomiting, diarrhea), fever.

If the side effects are mild, discontinuation of the drug is not required. If a hypersensitivity reaction occurs, drug withdrawal is recommended.

Interaction

The drugs can be used simultaneously with other drugs, including antibiotics.

How to take, course of administration and dosage

Adults and children over 12 years of age are prescribed Broncho-munal® at a dose of 7 mg; children aged 6 months to 12 years are prescribed Broncho-munal® P at a dose of 3.5 mg.

The drug is taken in the morning on an empty stomach, 1 capsule / day. If the patient/child cannot swallow the capsule, it is recommended to open it and dissolve the contents of the capsule in a small amount of liquid (tea, milk or juice).

For the prevention of infectious diseases of the respiratory tract, the drug is used in three 10-day courses with 20-day intervals between them.

In the acute period of the disease, 1 capsule / day is prescribed until the symptoms of the disease disappear, but not less than 10 days. In the next 2 months, prophylactic use of the drug is possible, 1 caps. within 10 days with a 20-day interval between courses.

Overdose

There were no clinical symptoms of overdose.

There are no reports of intoxication due to drug overdose.

Special Instructions

Between the use of oral vaccines and taking Broncho-munal, a 4-week interval should be observed.

It is not recommended to use the drug in acute intestinal diseases due to a possible decrease in the effectiveness of the drug.

Pediatric use

The drug is not prescribed to children under the age of 6 months.

To avoid overdose, children from 6 months to 12 years of age are prescribed only Broncho-munal® P (capsules containing 3.5 mg of lyophilisate).

Influence on the ability to drive vehicles and control mechanisms

No special precautions required.

Release form

Capsules

Storage conditions

At 15-25°C

Best before date

5 years

Active substance

Bacterial lysates